ET
INSIDER · AIM · AIM ImmunoTech Inc. · CEO & PRESIDENT
Equels Thomas K
Every open-market transaction filed under this name, Sep 14 to Oct 23.
Filings
6
6 buys · 0 sells
Bought
$24K
open market, at cost
Sold
—
includes scheduled sales
Buys since
−20.3%
avg move from buy price, 6 priced
Filings
| Traded | Ticker | Company | Role | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|---|---|
| Oct 23 | AIM | AIM ImmunoTech Inc. | CEO & President | Buy | 31,675 | $0.16 | $5K | −3.7% |
| Oct 22 | AIM | AIM ImmunoTech Inc. | CEO & President | Buy | 31,250 | $0.16 | $5K | −5.5% |
| Sep 17 | AIM | AIM ImmunoTech Inc. | CEO & President | Buy | 24,000 | $0.21 | $5K | −26.0% |
| Sep 16 | AIM | AIM ImmunoTech Inc. | CEO & President | Buy | 11,000 | $0.21 | $2K | −26.7% |
| Sep 15 | AIM | AIM ImmunoTech Inc. | CEO & President | Buy | 22,000 | $0.22 | $5K | −30.3% |
| Sep 14 | AIM | AIM ImmunoTech Inc. | CEO & President | Buy | 5,900 | $0.22 | $1K | −29.7% |
"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.